- decreased hematocrit / MGI
- decreased body weight / MGI
- abnormal erythrocyte morphology / MGI
- increased mean corpuscular volume / MGI
- reticulocytosis / MGI
- increased heart weight / MGI
- decreased erythrocyte cell number / MGI
- increased liver weight / MGI
- abnormal erythrocyte physiology / MGI
- abnormal erythrocyte osmotic lysis / MGI
- increased spleen weight / MGI
- increased circulating bilirubin level / MGI
- increased circulating glucose level / MGI
- decreased mean corpuscular hemoglobin / MGI
- abnormal enzyme/coenzyme activity / MGI
- decreased mean corpuscular hemoglobin concentration / MGI
- lethality, incomplete penetrance / MGI
- postnatal lethality, incomplete penetrance / MGI
C3El.Cg-Gpi1b-m1Neu/Ieg
Status | Available to order |
EMMA ID | EM:01816 |
International strain name | C3El.Cg-Gpi1b-m1Neu/Ieg |
Alternative name | GPI4314 |
Strain type | Induced Mutant Strains : Chemically-induced |
Allele/Transgene symbol | Gpi1b-m1Neu |
Gene/Transgene symbol | Gpi1 |
Information from provider
Provider | Walter Pretsch |
Provider affiliation | Institute of Experimental Genetics, Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH) |
Genetic information | Point mutation GTG -> GAG resulting in an amino acid alteration Val -> Glu at position 118. |
Phenotypic information | Glucose-6-phosphate isomerase deficiency (approximately 60% residual activity in heterozygous and approximately 20% residual activity in homozygous mutants) in blood and other organs. |
Breeding history | C3H/El (47th generation). |
References |
|
Information from EMMA
Archiving centre | Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany |
Disease and phenotype information
MGI allele-associated human disease models
MGI phenotypes (allele matching)
MGI phenotypes (gene matching)
- decreased hematocrit / MGI
- decreased body weight / MGI
- prenatal lethality / MGI
- abnormal embryonic tissue morphology / MGI
- abnormal erythrocyte morphology / MGI
- increased mean corpuscular volume / MGI
- reticulocytosis / MGI
- increased heart weight / MGI
- decreased erythrocyte cell number / MGI
- increased liver weight / MGI
- abnormal erythrocyte physiology / MGI
- abnormal erythrocyte osmotic lysis / MGI
- increased spleen weight / MGI
- increased circulating bilirubin level / MGI
- increased circulating glucose level / MGI
- decreased mean corpuscular hemoglobin / MGI
- abnormal enzyme/coenzyme activity / MGI
- increased lung weight / MGI
- decreased mean corpuscular hemoglobin concentration / MGI
- lethality, incomplete penetrance / MGI
- postnatal lethality, incomplete penetrance / MGI
- prenatal lethality, complete penetrance / MGI
- embryonic lethality, complete penetrance / MGI
- embryonic lethality between implantation and placentation, complete penetrance / MGI
- preweaning lethality, complete penetrance / MGI
Literature references
- Linear dose-response relationship of erythrocyte enzyme-activity mutations in offspring of ethylnitrosourea-treated mice.;Charles D J, Pretsch W, ;1987;Mutation research;176;81-91; 3796661
- Glucose phosphate isomerase enzyme-activity mutants in Mus musculus: genetical and biochemical characterization.;Pretsch W, Merkle S, ;1990;Biochemical genetics;28;97-110; 2344351
- Glucose-6-phosphate isomerase deficiency associated with nonspherocytic hemolytic anemia in the mouse: an animal model for the human disease.;Merkle S, Pretsch W, ;1993;Blood;81;206-13; 8417789
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).